Table of Contents

2019 Month : May Volume : 8 Issue : 18 Page : 1435-1438

DIAGNOSTIC UTILITY OF AMACR EXPRESSION TO DIFFERENTIATE PROSTATE CARCINOMA FROM BENIGN HYPERPLASIA OF PROSTATE- A HOSPITAL BASED CROSS-SECTIONAL STUDY.

Sanat Biswas1, Manas Talukdar2

1Specialist Medical Officer, Department of Pathology, District Hospital Hooghly, Chinsurah, West Bengal, India.
2Assistant Professor, Department of Laboratory Medicine, Medical College, Kolkata, West Bengal, India.

References :

1

Epstein JI, Loton TL. The lower urinary tract and male genital system. In: Kumar V, Abbas AK, Fausto N, et al, eds. Robbins and Cotran pathologic basis of disesae. 9th edn. Philadelphia: Saunders Elsevier 2016.  

2

Ferlay J, Ervik M, Lam F, et al. Cancer Today (powered by GLOBOCAN 2018)IARC Cancer Base No. 15. 2018. https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf.

3

Humphrey PA, Amin MB, Berney DM, et al. Acinar adenocarcinoma. In: Moch H, Humphrey PA, Ulbright TM, et al, eds. WHO classification of tumours of the urinary, system and male genital organs. 4th edn. Lyon: International Agency for Research on Cancer 2016.    

4

Antenor JA, Han M, Roehl KA, et al. Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study. J Urol 2004;172(1):90-3.            

CrossRef | Google Scholar | PubMed
5

Harvey CJ, Pilcher J, Richenberg J, et al. Applications of transrectal ultrasound in prostate cancer. Br J Radiol 2012;85 Spec No 1:S3-17.         

CrossRef | Google Scholar | PubMed
6

Heidenreich A, Bastian PJ, Bellmunt J, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 2014;65(1):124-37.              

CrossRef | Google Scholar | PubMed
7

Hameed O, Humphrey PA. Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol 2005;22(1):88-104.            

CrossRef | Google Scholar | PubMed
8

Toi A, Neill MG, Lockwood GA, et al. The continuing importance of transrectal ultrasound identification of prostatic lesions. J Urol 2007;177(2):516-20.      

CrossRef | Google Scholar | PubMed
9

O’Malley FP, Grignon DJ, Shum DT. Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland. Virchows Arch A Pathol Anat Histopathol 1990;417(3):191-6. 

Google Scholar | PubMed
10

Shah RB, Zhou M, LeBlanc M, et al. Comparison of the basal cell–specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol 2002;26(9):1161-8.            

CrossRef | Google Scholar | PubMed
11

Wojno KJ, Epstein JI. The utility of basal cell–specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases. Am J Surg Pathol 1995;19(3):251-60.          

Google Scholar | PubMed
12

Bostwick DG, Srigley J, Grignon D, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 1993;24(8):819-32.            

CrossRef | Google Scholar | PubMed
13

Bostwick DG, Algaba F, Amin MB, et al. Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostate. Hum Pathol 1994;25(8):840.               

CrossRef | Google Scholar | PubMed
14

Gaudin PB, Reuter VE. Benign mimics of prostatic adenocarcinoma on needle biopsy. Anat Pathol 1997;2:111-34.            

Google Scholar | PubMed
15

Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 2001;25(11):1397-404.   

CrossRef | Google Scholar | PubMed
16

Luo J, Zha S, Gage WR, et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 2002;62(8):2220-6.  

CrossRef | Google Scholar | PubMed
17

Rubin MA, Zhou M, Dhanasekaran SM, et al. Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002;287(13):1662-70.  

CrossRef | Google Scholar | PubMed
18

Beach R, Gown AM, De Peralta-Venturina MN, et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol 2002;26(12):1588-96.                    

CrossRef | Google Scholar | PubMed
19

Yang XJ, Wu CL, Woda BA, et al. Expression of alpha-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 2002;26(7):921-5.

CrossRef | Google Scholar | PubMed
20

Jiang Z, Wu CL, Woda BA, et al. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol 2002;26(9):1169-74.    

CrossRef | Google Scholar | PubMed
21

Hariharan K, Padmanabha V. Demography and disease characteristics of prostate cancer in India. Indian J Urol 2016;32(2):103-8.          

CrossRef | Google Scholar | PubMed
22

Huang TH, Kuo JY, Huang YH, et al. Prostate cancer in young adults seventeen-year clinical experience of a single center. J Chin Med Assoc 2017;80(1):39-43.                        

CrossRef | Google Scholar | PubMed
23

Siegel R, Ma J, Zou Z, et al. Cancer statistics 2014. CA Cancer J Clin 2014;64(1):9-29.               

CrossRef | Google Scholar | PubMed
24

Lee YJ, Lee JW, Park J, et al. Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea. Investig Clin Urol 2016;57(6):424-30.       

CrossRef | Google Scholar | PubMed
25

Yeboah ED. Prevalence of benign prostatic hyperplasia and prostate cancer in Africans and Africans in the Diaspora. J West Afr Coll Surg 2016;6(4):1-30.         

CrossRef | Google Scholar | PubMed
26

Epstein JI. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol 1995;26(2):223-9.          

CrossRef | Google Scholar | PubMed
27

Kunju LP, Rubin MA, Chinnaiyan AM, et al. Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations. Am J Clin Pathol 2003;120(5):737-45.            

CrossRef | Google Scholar | PubMed
28

Magi-Galluzzi C, Luo J, Isaacs WB, et al. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Am J Surg Pathol 2003;27(8):1128-33.           

CrossRef | Google Scholar | PubMed
29

Kumaresan K, Kakkar N, Verma A, et al. Diagnostic utility of α-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer. Diagn Pathol 2010;5:83.                          

CrossRef | Google Scholar | PubMed